THERANOSTICS 润色咨询

Theranostics

出版年份:2011 年文章数:3138 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:7.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-12-04 Mr.Never Die

    口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两

    16

    展开16条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2021-01-27 wodesinianbuhuifei

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2021-01-03 1e0cf3e5m18(暂无匿称)

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投

    26

    展开26条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2021-01-13 dnsnns

    做肿瘤的为啥投这个期刊自己心里不清楚么

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-12-05 rains1979

    molecular cancer 不是一样的的吗,大量综述,70%国人发文量

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2021-01-07 1459b6c3m33暂无昵称

    卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-08-04 bigapple001

    依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-12-20 真实的科研小工

    审稿速度:1.0
    经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-04-22 148a9df0m66暂无昵称

    我看我的那两个也不能替换了,可能是送审了130****1010暂无昵称 2020-04-21 发表::
    我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑
    130****1010暂无昵称 2020-04-21 00:00:00 发表:
    我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑

    130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=904942, encodeId=162390494233, content=口碑差为啥这么差 你们心里没点b数吗?,无非是想投八分以上期刊 其他的够不上就只能往这投了呗,真觉得自己的研究那么有价值吗?做人呐,最可悲的莫过于看不清自己几斤几两, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKlT8dqnB7dRUwHjSjzxzL0qta9ib7ZLaLnNhoRG8YDiaKp8zia3TrSBWt1nMZIZUsovyePuKtLCFTOQ/132, createdBy=7b782000120, createdName=Mr.Never Die, createdTime=Fri Dec 04 17:59:40 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920471, encodeId=9c579204e19a, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:接收后提交完Final files received for publication有最终的提交按钮吗,多久之后这些文件不能再改了,是交完版面费之后吗?求告知🙏🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05475456644, createdName=wodesinianbuhuifei, createdTime=Wed Jan 27 23:33:57 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913304, encodeId=4e2991330457, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:高分低能水刊,水刊的一种版本,中国占比超过九成,外国人不屑投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=749, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Sun Jan 03 14:39:24 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916261, encodeId=5823916261ee, content=做肿瘤的为啥投这个期刊自己心里不清楚么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201007/099799ef0ff74292905c59b2424469f9/6f0aff90a8294f3c89413e6d03feb011.jpg, createdBy=8edf2386442, createdName=dnsnns, createdTime=Wed Jan 13 16:18:40 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905172, encodeId=9e179051e2ca, content=molecular cancer 不是一样的的吗,大量综述,70%国人发文量, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44ce21017, createdName=rains1979, createdTime=Sat Dec 05 13:08:32 CST 2020, time=2020-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914264, encodeId=e72b914264f7, content=卑微求问各位大佬们,这个杂志一般投稿多久送审?一审拒稿率高不高?谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c13d5073868, createdName=1459b6c3m33暂无昵称, createdTime=Thu Jan 07 01:07:09 CST 2021, time=2021-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806014, encodeId=6df280601458, content=依托于厦门大学的“潜藏”国产期刊,以前中过一篇,5个审稿人提了70多个问题,还蛮严谨的。不知道为什么最近口碑不太好,可能中国人发的多了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=231, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Tue Aug 04 07:28:53 CST 2020, time=2020-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909481, encodeId=6f7c90948189, content=审稿速度:1.0<br>经验分享:杂志效率惊人,一审两周不到,两个审稿人十多个问题,大修一个月,修回第二天接收。就是PubMed更新太慢😄, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ac35401085, createdName=真实的科研小工, createdTime=Sun Dec 20 00:45:42 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589468, encodeId=dd1d589468fb, content=我看我的那两个也不能替换了,可能是送审了<span class="quote">130****1010暂无昵称 2020-04-21 发表::<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span><span class="quote">130****1010暂无昵称 2020-04-21 00:00:00 发表:<br>我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑</span>, beContent=130****1010暂无昵称 2020-04-21 发表:: 我的现在MS和cover不能replace了,不知道有没有关系,还是只显示under review。有消息互通一下哈,比较忐忑, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e555320707, createdName=148a9df0m66暂无昵称, createdTime=Wed Apr 22 00:00:00 CST 2020, time=2020-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888895, encodeId=e8ce88889506, content=审稿速度:1.0<br>经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201019/4b4bb41d91c344638c4646860774486f/8e4b49c830ff47b09271b2baf9987dd2.jpg, createdBy=19a93002970, createdName=425503904, createdTime=Mon Sep 28 13:36:59 CST 2020, time=2020-09-28, status=1, ipAttribution=)]
    2020-09-28 425503904

    审稿速度:1.0
    经验分享:为什么这个杂志的囗碑这么差阿?刚接收了一篇,希望IF能稳住。好不容易发了个高分的,都有点不好意思跟别人讲

    12

    展开12条回复
共500条页码: 7/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分